osimertinib  - Drug Details
📊 Estimates osimertinib  Dialyzability By Different_Modalities

osimertinib 

Complete Drug Information

Drug Name
osimertinib 
Trade Names
Tagrisso
Pregnancy Category
AU: D
Routes of Administration
Oral
Protein Binding
Probably high%
Metabolism
Oxidation (CYP3A)
Elimination
48 hours
Excretion
Feces (68%), urine (14%)
Formula
C28H33N7O2
Molar Mass
499.619
Volume of Distribution
997 L/kg

🤰 Pregnancy Category Information

Category: AU: D

Drugs which have caused, are suspected to have caused, or may be expected to cause an increased incidence of human fetal malformations or irreversible damage. These drugs may also have adverse pharmacological effects.